Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
Authors: Dhayat NA; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Faller N; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Bonny O; Department of Nephrology, CHUV, University Hospital Lausanne, University of Lausanne, Lausanne, Switzerland., Mohebbi N; Department of Nephrology, University Hospital Zurich, Zürich, Switzerland., Ritter A; Department of Nephrology, University Hospital Zurich, Zürich, Switzerland., Pellegrini L; Department of Nephrology, Regional Hospital Lugano, Lugano, Switzerland., Bedino G; Department of Nephrology, Regional Hospital Lugano, Lugano, Switzerland., Schönholzer C; Department of Nephrology, Regional Hospital Lugano, Lugano, Switzerland., Venzin RM; Department of Nephrology, Cantonal Hospital Chur, Chur, Switzerland., Hüsler C; Department of Nephrology and Transplantation Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Koneth I; Department of Nephrology and Transplantation Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Del Giorno R; Department of Nephrology, Regional Hospital Bellinzona, Bellinzona, Switzerland., Gabutti L; Department of Nephrology, Regional Hospital Bellinzona, Bellinzona, Switzerland., Amico P; Medical Outpatient Department, University Hospital Basel, University of Basel, Basel, Switzerland., Mayr M; Medical Outpatient Department, University Hospital Basel, University of Basel, Basel, Switzerland., Odermatt U; Department of Nephrology, Cantonal Hospital Luzern, Luzern, Switzerland., Buchkremer F; Division of Nephrology, Dialysis and Transplantation, Cantonal Hospital Aarau, Aarau, Switzerland., Ernandez T; Department of Nephrology, HUG, University Hospital Geneva, University of Geneva, Geneva, Switzerland., Stoermann-Chopard C; Department of Nephrology, HUG, University Hospital Geneva, University of Geneva, Geneva, Switzerland., Teta D; Service de Nephrology, Centre Hospitalier du Valais Romand (CHVR), Sion, Switzerland., Rintelen F; Clinical Trials Unit, University of Bern, Bern, Switzerland., Roumet M; Clinical Trials Unit, University of Bern, Bern, Switzerland., Irincheeva I; Clinical Trials Unit, University of Bern, Bern, Switzerland., Trelle S; Clinical Trials Unit, University of Bern, Bern, Switzerland., Tamò L; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Clinical Trials Unit, University of Bern, Bern, Switzerland., Roth B; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Vogt B; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Fuster DG; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. daniel.fuster@insel.ch.
Source: BMC nephrology [BMC Nephrol] 2018 Dec 10; Vol. 19 (1), pp. 349. Date of Electronic Publication: 2018 Dec 10.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first